The update of idiopathic intracranial hypertension and related oculopathy

doi:10.3877/cma.j.issn.2095-5782.2020.03.006

Abstract

Abstract:

Idiopathic intracranial hypertension(IIH) is characterized by severe headache and visual impairment, which is attracting more and more attention recent years.This article systematically reviews the the current status of demography, pathophysiology, diagnosis and treatment for IIH and related oculopathy, in order to provide a more comprehensive idea for clinical diagnosis and treatment.

Key words: Idiopathic intracranial hypertension, Oculopathy, Treatment

Ke Li, Feng Wang. The update of idiopathic intracranial hypertension and related oculopathy[J]. Chinese Journal of Interventional Radiology(Electronic Edition), 2020, 08(03): 221-226.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhjrfsxdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-5782.2020.03.006

https://zhjrfsxdzzz.cma-cmc.com.cn/EN/Y2020/V08/I03/221

References 40

[1]	Corbett JJ, Savino PJ, Thompson HS, et al.Visual loss in pseudotumor cerebri. Follow-up of 57 patients from five to 41 years and a profile of 14 patients with permanent severe visual loss[J].Arch Neurol, 1982, 39(8): 461-474.
[2]	Best J, Silvestri G, Burton B, et al.The incidence of blindness due to idiopathic intracranial hypertension in the UK[J]. Open Ophthalmol J, 2013, 7: 26-29.
[3]	D AD, Curone M, Ciasca P, et al.Headache prevalence and clinical features in patients with idiopathic intracranial hypertension (IIH)[J]. Neurol Sci, 2013, 34(Suppl) 1: s147-149.
[4]	Radhakrishnan K, Thacker AK, Bohlaga NH, et al.Epidemiology of idiopathic intracranial hypertension: A prospective and case-control study[J]. J Neurol Sci, 1993, 116(1): 18-28.
[5]	Friedman DI.The pseudotumor cerebri syndrome[J]. Neurol Clin, 2014, 32(2): 363-396.
[6]	Quincke H. Meningitis serosa[J]. Sammlung Klinischer Vortrage Innere Medizin, 1893, 67: 655.
[7]	Nonne M. Uber Falle vom Symtomkomplex "Tumor Cerebri" mit Ausgang in Heilung "Pseudotumor Cerebri"[J]．Nervenheilkunde, 1904, 27: 169-216．
[8]	Dandy WE.intracranial pressure without brain tumor: Diagnosis and treatment[J]. Ann Surg, 1937, 106(4): 492-513.
[9]	Foley J.Benign forms of intracranial hypertension: Toxic and otitic hydrocephalus[J]. Brain, 1955, 78(1): 1-41.
[10]	Buchheit WA, Burton C, Haag B, et al.Papilledema and idiopathic intracranial hypertension[J]. N Engl J Med, 1969, 280(17): 938-942.
[11]	Smith JL. Whence pseudotumor cerebri?[J]. J Clin Neuroophthalmol, 1985, 5(1): 55-56.
[12]	Friedman DI, Jacobson DM.Diagnostic criteria for idiopathic intracranial hypertension[J]. Neurology, 2002, 59(10): 1492-1495.
[13]	Cserr HF. Role of secretion and bulk flow of brain interstitial fluid in brain volume regulation[J]. Ann N Y Acad Sci, 1988, 529: 9-20.
[14]	Iliff JJ, Wang M, Liao Y, et al.A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid beta[J]. Sci Transl Med, 2012, 4(147): 147ra111.
[15]	Toscano V, Sancesario G, Bianchi P, et al. Cerebrospinal fluid estrone in pseudotumor cerebri: A change in cerebral steroid hormone metabolism?[J]. J Endocrinol Invest, 1991, 14(2): 81-86.
[16]	Tomsak RL, Niffenegger AS, Remler BF. Treatment of pseudotumor cerebri with Diamox (acetazolamide)[J]. J Clin Neuroophthalmol, 1988, 18: 93-98．
[17]	Ko MW, Chang SC, Ridha MA, et al. Weight gain and recurrence in idiopathic intracranial hypertension: A case-control study[J]. Neurology, 2011, 76(18): 1564-1567.
[18]	Johnson LN, Krohel GB, Madsen RW, et al. The role of weight loss and acetazolamide in the treatment of idiopathic intracranial hypertension (pseudotumor cerebri)[J]. Ophthalmology, 1998,105(12): 2313-2317.
[19]	Sinclair AJ, Burdon MA, Nightingale PG, et al. Low energy diet and intracranial pressure in women with idiopathic intracranial hypertension: prospective cohort study[J]. BMJ, 2010(341): c2701.
[20]	Farb RI, Vanek I, Scott JN, et al.Idiopathic intracranial hypertension: The prevalence and morphology of sinovenous stenosis[J]. Neurology, 2003, 60(9): 1418-1424.
[21]	King JO, Mitchell PJ, Thomson KR, et al. Cerebral venography and manometry in idiopathic intracranial hypertension[J]. Neurology, 1995, 45(12): 2224-2228.
[22]	Case D, Seinfeld J, Roark C, et al. Idiopathic intracranial hypertension: Contemporary management and endovascular techniques[J]. Semin Intervent Radiol, 2020, 37(2): 175-181.
[23]	Yri HM, Ronnback C, Wegener M, et al. The course of headache in idiopathic intracranial hypertension: A 12-month prospective follow-up study[J]. Eur J Neurol, 2014, 21(12): 1458-1464.
[24]	Karahalios DG, Rekate HL, Khayata MH, et al. Elevated intracranial venous pressure as a universal mechanism in pseudotumor cerebri of varying etiologies[J]. Neurology, 1996, 46(1): 198-202.
[25]	Huna-Baron R, Landau K, Rosenberg M, et al. Unilateral swollen disc due to increased intracranial pressure[J]. Neurology, 2001, 56(11): 1588-1590.
[26]	Wall M, George D. Idiopathic intracranial hypertension:A prospective study of 50 patients[J]. Brain, 1991, 114 (Pt 1A): 155-180.
[27]	Thambisetty M, Lavin PJ, Newman NJ, et al. Fulminant idiopathic intracranial hypertension[J]. Neurology, 2007, 68(3): 229-232.
[28]	Sadun AA, Currie JN, Lessell S.Transient visual obscurations with elevated optic discs[J]. Ann Neurol, 1984, 16(4): 489-494.
[29]	Yang IH, Pereira VM, Lenck S, et al. Endovascular treatment of debilitating tinnitus secondary to cerebral venous sinus abnormalities: A literature review and technical illustration[J].J Neurointerv Surg, 2019, 11(8): 841-846.
[30]	Sinclair AJ, Burdon MA, Nightingale PG, et al. Rating papilloedema: An evaluation of the Frisen classification in idiopathic intracranial hypertension[J]. J Neurol, 2012, 259(7): 1406-1412.
[31]	Wang JK, Kardon RH, Kupersmith MJ, et al. Automated quantification of volumetric optic disc swelling in papilledema using spectral-domain optical coherence tomography[J]. Invest Ophthalmol Vis Sci, 2012, 53(7): 4069-4075.
[32]	Piper RJ, Kalyvas AV, Young AM, et al. Interventions for idiopathic intracranial hypertension[J]. Cochrane Database Syst Rev, 2015(8): CD003434.
[33]	Newborg B. Pseudotumor cerebri treated by rice reduction diet[J].Arch Intern Med, 1974, 133(5): 802-807.
[34]	Sinclair AJ, Burdon MA, Nightingale PG, et al. Low energy diet and intracranial pressure in women with idiopathic intracranial hypertension: Prospective cohort study[J]. BMJ, 2010, 341: c2701.
[35]	Biousse V, Bruce BB, Newman NJ. Update on the pathophysiology and management of idiopathic intracranial hypertension[J].J Neurol Neurosurg Psychiatry, 2012, 83(5): 488-494.
[36]	Wall M, McDermott MP, Kieburtz KD, et al. Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: The idiopathic intracranial hypertension treatment trial[J]. JAMA, 2014, 311(16): 1641-1651.
[37]	Thambisetty M, Lavin PJ, Newman NJ, et al. Fulminant idiopathic intracranial hypertension[J]. Neurology, 2007, 68(3): 229-232.
[38]	Satti SR, Leishangthem L, Chaudry MI. Meta-analysis of CSF diversion procedures and dural venous sinus stenting in the setting of medically refractory idiopathic intracranial hypertension[J]. AJNR Am J Neuroradiol, 2015, 36(10): 1899-1904.
[39]	Lee AG. Visual loss as the manifesting symptom of ventriculoperitoneal shunt malfunction[J]. Am J Ophthalmol, 1996, 122(1):127-129.
[40]	Liu GT, Volpe NJ, Schatz NJ, et al. Severe sudden visual loss caused by pseudotumor cerebri and lumboperitoneal shunt failure[J]. Am J Ophthalmol, 1996, 122(1): 129-131.

Please choose a citation manager

Content to export